CNS clinical trials : suicidality and data collection : workshop summary /

Saved in:
Bibliographic Details
Imprint:Washington, D.C. : National Academies Press, c2010.
Description:xii, 75 p. : ill. ; 23 cm.
Language:English
Subject:
Format: E-Resource Print Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/8359489
Hidden Bibliographic Details
Varying Form of Title:Central nervous system clinical trials
Other authors / contributors:Hanson, Sarah L. (Sarah Lynn), 1980-
Davis, Miriam (Medical writer).
Altevogt, Bruce M.
Institute of Medicine (U.S.). Forum on Neuroscience and Nervous System Disorders.
National Academies Press (U.S.)
ISBN:9780309148832
0309148839
Notes:Includes bibliographical references (p. 43-49).
Also issued online.
Summary:"The Food and Drug Administration (FDA) now requires that all clinical trials for drugs that affect the central nervous system--including psychiatric drugs--are assessed for whether that drug might cause suicidal ideation or behavior. The Institute of Medicine's (IOM) Forum on Neuroscience and Nervous System Disorders hosted a meeting on June 26, 2009, to discuss the FDA's new policy and how to analyze best whether suicidal thoughts predict actual suicidal behavior in the near future."--Publisher's description.

Crerar, Lower Level, Bookstacks

Loading map link
Holdings details from Crerar, Lower Level, Bookstacks
Call Number: RC569 .C67 2010
c.1 Available Loan period: standard loan  Scan and Deliver Request for Pickup Need help? - Ask a Librarian